C
Chester H. Fox
Researcher at University at Buffalo
Publications - 84
Citations - 3756
Chester H. Fox is an academic researcher from University at Buffalo. The author has contributed to research in topics: Health care & Kidney disease. The author has an hindex of 25, co-authored 82 publications receiving 3001 citations. Previous affiliations of Chester H. Fox include State University of New York System.
Papers
More filters
Journal ArticleDOI
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
Lesley A. Inker,Brad C. Astor,Chester H. Fox,Tamara Isakova,James P. Lash,Carmen A. Peralta,Manjula Kurella Tamura,Harold I. Feldman +7 more
TL;DR: The National Kidney Foundation-KDOQI guideline for evaluation, classification, and stratification of chronic kidney disease (CKD) was published in 2002 as mentioned in this paper, but concerns and criticisms arose as new evidence became available since the publication of the original guidelines.
KDOQI Commentary KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
Lesley A. Inker,Brad C. Astor,Chester H. Fox,Tamara Isakova,James P. Lash,Carmen A. Peralta,Manjula Kurella Tamura,Harold I. Feldman +7 more
TL;DR: A work group agreed with most of the recommendations contained in the KDIGO guidelines, particularly the recommendations regarding the definition and classification of CKD, however, there were some concerns about incorporating the cause of disease into CKD classification.
Journal ArticleDOI
Fistula First Breakthrough Initiative: Targeting Catheter Last in Fistula First
Joseph A. Vassalotti,Joseph A. Vassalotti,William C. Jennings,Gerald A. Beathard,Marianne Neumann,Susan Caponi,Chester H. Fox,Lawrence M. Spergel +7 more
TL;DR: The AVF First breakthrough initiative should include specific CVC usage target(s), based on the KDOQI goal of less than 10% in patients undergoing HD for more than 90 days, and a substantially improved initial target from the current CVC proportion.
Journal ArticleDOI
BI-RADS classification for management of abnormal mammograms.
TL;DR: The Breast Imaging Reporting and Data System (BI-RADS), developed by the American College of Radiology, provides a standardized classification for mammographic studies and demonstrates good correlation with the likelihood of breast malignancy.
Journal Article
Magnesium: its proven and potential clinical significance.
TL;DR: Randomized clinical trials are urgently needed to determine whether magnesium supplementation will alter the natural history of chronic cardiovascular diseases, including hypertension, diabetes mellitus, and hyperlipidemia.